A real-world study of PsO and PsA. patients with apremilast reported no new adverse events with results comparable to clinical trials.

Treatment with apremilast appears to be associated with fat loss in patients with psoriasis, according to new study results. The findings...

The researchers analyzed the electronic health records of more than 700 general practices in the U.K. between 2010 and 2017, comparing...

A new real-world study showed IL-23 inhibitors to be highly effective for the treatment of chronic plaque psoriasis.

A proof-of-concept study in four patients has shown that an epidural nerve block using lidocaine can lead to clearance of psoriatic skin...

Patients with psoriasis have a 20% greater risk of organ-based comorbidities when compared with the general population.

Researchers have found that the hormone estradiol suppresses psoriasis, providing a basis for therapeutic potential.

The global prevalence of metabolic syndrome (MetS) among patients with psoriasis is 32%, researchers report online in the Journal of the...